Tokyo Tape
Sign in
← Hyuga Primary Care

Quarterly report · Q1

7133.TEDINET S100RMC7
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 35
MetricValuePeriodScopeSource row
Revenue¥1.8bn2023-04-01 → 2023-06-30StandaloneNet sales
Revenue¥6.7bn2022-04-01 → 2023-03-31StandaloneNet sales (5-year summary)
Revenue¥1.5bn2022-04-01 → 2022-06-30StandaloneNet sales
Operating income¥56m2023-04-01 → 2023-06-30StandaloneOperating income
Operating income¥129m2022-04-01 → 2022-06-30StandaloneOperating income
Ordinary income¥55m2023-04-01 → 2023-06-30StandaloneOrdinary income
Ordinary income¥558m2022-04-01 → 2023-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥138m2022-04-01 → 2022-06-30StandaloneOrdinary income
Profit before tax¥55m2023-04-01 → 2023-06-30StandaloneIncome before income taxes
Profit before tax¥138m2022-04-01 → 2022-06-30StandaloneIncome before income taxes
Net income¥37m2023-04-01 → 2023-06-30StandaloneProfit loss
Net income¥383m2022-04-01 → 2023-03-31StandaloneNet income loss (5-year summary)
Net income¥92m2022-04-01 → 2022-06-30StandaloneProfit loss
Total assets¥3.1bnat 2023-06-30StandaloneAssets
Total assets¥2.9bnat 2023-03-31StandaloneAssets
Total assets¥2.6bnat 2022-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥1.5bnat 2023-06-30StandaloneLiabilities
Total liabilities¥1.4bnat 2023-03-31StandaloneLiabilities
Net assets / equity¥1.5bnat 2023-06-30StandaloneNet assets
Net assets / equity¥1.5bnat 2023-03-31StandaloneNet assets
Net assets / equity¥1.2bnat 2022-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥504mat 2023-06-30StandaloneCash and deposits
Cash and deposits¥568mat 2023-03-31StandaloneCash and deposits
EPS (basic)¥5.112023-04-01 → 2023-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥53.922022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥13.082022-04-01 → 2022-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥4.862023-04-01 → 2023-06-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥50.822022-04-01 → 2023-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥12.182022-04-01 → 2022-06-30StandaloneDiluted earnings per share (5-year summary)
Equity ratio49.9%at 2023-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio50.9%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio44.7%at 2022-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued7,156,600at 2023-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued3,572,000at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued3,519,500at 2022-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-06-30¥7m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-06-30¥7m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-06-30−¥4m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥116m
jpcrp040300-q1r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue2023-04-01 → 2023-06-30¥1.5bn
jpcrp040300-q1r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue external2023-04-01 → 2023-06-30¥1.5bn
jpcrp040300-q1r_E37198-000Home Visit Pharmacist Servicereportable segmentsegment profit2023-04-01 → 2023-06-30¥124m
jpcrp040300-q1r_E37198-000Kirari Primereportable segmentrevenue2023-04-01 → 2023-06-30¥177m
jpcrp040300-q1r_E37198-000Kirari Primereportable segmentrevenue external2023-04-01 → 2023-06-30¥177m
jpcrp040300-q1r_E37198-000Kirari Primereportable segmentsegment profit2023-04-01 → 2023-06-30¥90m
jpcrp040300-q1r_E37198-000Primary Care Homereportable segmentrevenue2023-04-01 → 2023-06-30¥106m
jpcrp040300-q1r_E37198-000Primary Care Homereportable segmentrevenue external2023-04-01 → 2023-06-30¥106m
jpcrp040300-q1r_E37198-000Primary Care Homereportable segmentsegment profit2023-04-01 → 2023-06-30−¥39m
—segment totalrevenue2023-04-01 → 2023-06-30¥1.8bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥1.8bn
—segment totalsegment profit2023-04-01 → 2023-06-30¥176m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-06-30¥1.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-06-30¥1.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-06-30¥172m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥17m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥17m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30¥4m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥86m
jpcrp040300-q1r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue2022-04-01 → 2022-06-30¥1.4bn
jpcrp040300-q1r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue external2022-04-01 → 2022-06-30¥1.4bn
jpcrp040300-q1r_E37198-000Home Visit Pharmacist Servicereportable segmentsegment profit2022-04-01 → 2022-06-30¥153m
jpcrp040300-q1r_E37198-000Kirari Primereportable segmentrevenue2022-04-01 → 2022-06-30¥134m
jpcrp040300-q1r_E37198-000Kirari Primereportable segmentrevenue external2022-04-01 → 2022-06-30¥134m
jpcrp040300-q1r_E37198-000Kirari Primereportable segmentsegment profit2022-04-01 → 2022-06-30¥71m
jpcrp040300-q1r_E37198-000Primary Care Homereportable segmentrevenue2022-04-01 → 2022-06-30¥32m
jpcrp040300-q1r_E37198-000Primary Care Homereportable segmentrevenue external2022-04-01 → 2022-06-30¥32m
jpcrp040300-q1r_E37198-000Primary Care Homereportable segmentsegment profit2022-04-01 → 2022-06-30−¥14m
—segment totalrevenue2022-04-01 → 2022-06-30¥1.5bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥1.5bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥210m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥1.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥1.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥215m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 288
ItemContextValueUnit
Independent auditors report non consolidated (text)FilingDateInstantText · Plus
Audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)有限責任監査法人ト　ー　マ　ツ
Cpa1 audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)宮　本　芳　樹
Cpa2 audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)下　平　雅　和
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1YTDDuration_NonConsolidatedMember1534780000JPY
Net sales (5-year summary)CurrentYTDDuration_NonConsolidatedMember1795201000JPY
Net sales (5-year summary)Prior1YearDuration_NonConsolidatedMember6657448000JPY
Ordinary income loss (5-year summary)Prior1YTDDuration_NonConsolidatedMember137553000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration_NonConsolidatedMember55271000JPY
Ordinary income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember557751000JPY
Net income loss (5-year summary)Prior1YTDDuration_NonConsolidatedMember91752000JPY
Net income loss (5-year summary)CurrentYTDDuration_NonConsolidatedMember36519000JPY
Net income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember382876000JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior1YTDDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)CurrentYTDDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior1YearDuration_NonConsolidatedMember－JPY
Capital stock (5-year summary)Prior1QuarterInstant_NonConsolidatedMember175832000JPY
Capital stock (5-year summary)CurrentQuarterInstant_NonConsolidatedMember187121000JPY
Capital stock (5-year summary)Prior1YearInstant_NonConsolidatedMember185912000JPY
Total number of issued shares (5-year summary)Prior1QuarterInstant_NonConsolidatedMember3519500
Total number of issued shares (5-year summary)CurrentQuarterInstant_NonConsolidatedMember7156600
Total number of issued shares (5-year summary)Prior1YearInstant_NonConsolidatedMember3572000
Net assets (5-year summary)Prior1QuarterInstant_NonConsolidatedMember1171850000JPY
Net assets (5-year summary)CurrentQuarterInstant_NonConsolidatedMember1522073000JPY
Net assets (5-year summary)Prior1YearInstant_NonConsolidatedMember1483134000JPY
Total assets (5-year summary)Prior1QuarterInstant_NonConsolidatedMember2621471000JPY
Total assets (5-year summary)CurrentQuarterInstant_NonConsolidatedMember3052475000JPY
Total assets (5-year summary)Prior1YearInstant_NonConsolidatedMember2914911000JPY
Basic earnings loss per share (5-year summary)Prior1YTDDuration_NonConsolidatedMember13.08
Basic earnings loss per share (5-year summary)CurrentYTDDuration_NonConsolidatedMember5.11
Basic earnings loss per share (5-year summary)Prior1YearDuration_NonConsolidatedMember53.92
Diluted earnings per share (5-year summary)Prior1YTDDuration_NonConsolidatedMember12.18
Diluted earnings per share (5-year summary)CurrentYTDDuration_NonConsolidatedMember4.86
Diluted earnings per share (5-year summary)Prior1YearDuration_NonConsolidatedMember50.82
Dividend paid per share (5-year summary)Prior1YTDDuration_NonConsolidatedMember－
Dividend paid per share (5-year summary)CurrentYTDDuration_NonConsolidatedMember－
Dividend paid per share (5-year summary)Prior1YearDuration_NonConsolidatedMember－
Equity to asset ratio (5-year summary)Prior1QuarterInstant_NonConsolidatedMember0.447
Equity to asset ratio (5-year summary)CurrentQuarterInstant_NonConsolidatedMember0.499
Equity to asset ratio (5-year summary)Prior1YearInstant_NonConsolidatedMember0.509
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember7156600
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember7156600
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant7156600
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant7156600
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2023-03-31pass rounding
balance sheet identitynon_consolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2023-06-30pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-06-30pass
statement vs summary · revenuenon_consolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2023-06-30pass